amylyx

Amylyx Pharmaceuticals is a clinical-stage biotechnology company focused on developing treatments for diseases with high unmet needs, including post-bariatric hypoglycemia, Wolfram syndrome, and amyotrophic lateral sclerosis. The company is committed to rigorous science and a culture of caring, aiming to make a significant impact on the communities it serves.